Hippocampus/Pituitary Ratio: an AD Brain Injury Marker?
Hippocampus/Pituitary Ratio: an AD Brain Injury Marker?
批准号:
6881420
负责人:
THOMAS P BERESFORD
金额:
$12.6万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-05 至 2007-03-31
关键词:
adult human (21+)alcoholic beverage consumptionalcoholism /alcohol abusebrain imaging /visualization /scanningbrain injurybrain morphologyclinical researchcortisolhippocampushuman subjecthypercortisolismhypothalamic pituitary axisimmunologic assay /testlongitudinal human studymagnetic resonance imagingmaleneural information processingpatient oriented researchpituitary glandpsychopathology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Possible disorders of the hypothalamic-pituitary-adrenal (HPA) endocrine axis have been implicated in both clinical and behavioral pathology resulting from the prolonged, heavy drinking of Alcohol Dependence. (AD) Studies report abnormally high levels of cortisol secretion during ethanol withdrawal as well as non-suppression of diurnal cortisol after dexamethasone in AD sufferers. Others found such neuro-endocrine abnormalities more frequently among Wernicke-Korsakoff Syndrome cases, suggesting a possible relation to brain injury. Studies from primates support this, observing chronically high levels of serum cortisol associated with degeneration of the hippocampal tissue. Noting previous research, we hypothesized that an increase in pituitary volume and a reduction in hippocampal volume would identify a sample of chronic, active, heavy drinkers. From volume measurements acquired by MRI scanning, we found that a decreased ratio of the hippocampus-to-pituitary volume (H:P ratio) characterized a group of recent, heavy drinkers as compared to a non-drinking control group. Although intriguing, this study was done in a convenience sample. We now propose to perform and extend this inquiry in a prospective fashion in order to establish whether a reduced H:P volume ratio serves
as a state marker among AD subjects. If so, we ask a) does this indicate a reversible physiologic consequence of drinking or permanent structural change, and b) is reduced H:P ratio associated with hypercortisolemia, indicating loss of hippocampal feedback as a possible physiologic mechanism? To answer these questions, we will 1) measure baseline H:P volume ratios in 30, actively drinking, AD test subjects and in 30 matched, non-heavy drinking, non-AD control subjects, 2) measure H:P volume ratios serially in AD subjects after six months of ethanol abstinence, and 3) measure diurnal salivary cortisol secretion at baseline for both groups and serially for AD subjects. From this study we expect to develop valid, prospectively gathered, data that can begin to establish the clinical and patho-physiologic meaning of the decrease in the H:P volume ratio. We believe this line of investigation will ultimately shed new light on an important aspect of altered brain function due to sustained ethanol exposure as well as recovery of neuroendocrine functioning after cessation of heavy alcohol use.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Disulfiram therapy in patients with hepatitis C: a 12-month, controlled, follow-up study.
丙型肝炎患者的双硫仑治疗:一项为期 12 个月的对照随访研究。
DOI:
10.15288/jsa.2004.65.651
发表时间:
2004
期刊:
Journal of studies on alcohol
影响因子:
--
作者:
[Martin,Brandon, Alfers,Julie, Kulig,Clark, Clapp,Lori, Bialkowski,Diana, Bridgeford,Denise, Beresford,ThomasP]
通讯作者:
Beresford,ThomasP
Establishing the Molecular Mechanisms of Reduced Ethanol Drinking in Calcineurin-Mediated Immunosuppression Treated Rodents
-
批准号:10847322
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:THOMAS P BERESFORD
-
依托单位:
Establishing the Molecular Mechanisms of Reduced Ethanol Drinking in Calcineurin-Mediated Immunosuppression Treated Rodents
-
批准号:10477241
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:THOMAS P BERESFORD
-
依托单位:
Establishing the Molecular Mechanisms of Reduced Ethanol Drinking in Calcineurin-Mediated Immunosuppression Treated Rodents
-
批准号:10200665
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:THOMAS P BERESFORD
-
依托单位:
Neuro-immunophyllin Ligand Mechanism of Action in Reducing Alcohol Preference
-
批准号:7388423
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2008
-
负责人:THOMAS P BERESFORD
-
依托单位:
Neuro-immunophyllin Ligand Mechanism of Action in Reducing Alcohol Preference
-
批准号:7691408
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2008
-
负责人:THOMAS P BERESFORD
-
依托单位:
Fatty Acid Ethyl Esters as an Indicator of Ethanol Use
-
批准号:6982165
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2004
-
负责人:THOMAS P BERESFORD
-
依托单位:
Hippocampus /Pituitary Ratio and Alcohol Dependence
-
批准号:6570024
-
项目类别:
-
资助金额:$12.48万
-
财政年份:2003
-
负责人:THOMAS P BERESFORD
-
依托单位:
Hippocampus/Pituitary Ratio: an AD Brain Injury Marker?
-
批准号:6732059
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2003
-
负责人:THOMAS P BERESFORD
-
依托单位:
PLANNING A CLINICAL TRIAL TO PREVENT POSTTRANSPLANT ALD
-
批准号:2894273
-
项目类别:
-
资助金额:$6.3万
-
财政年份:1998
-
负责人:THOMAS P BERESFORD
-
依托单位:
PLANNING A CLINICAL TRIAL TO PREVENT POSTTRANSPLANT ALD
-
批准号:2766664
-
项目类别:
-
资助金额:$6.3万
-
财政年份:1998
-
负责人:THOMAS P BERESFORD
-
依托单位:
CLINICAL RESEARCH TRAINING IN ALCOHOLISM
-
批准号:3530067
-
项目类别:
-
资助金额:$13.86万
-
财政年份:1990
-
负责人:THOMAS P BERESFORD
-
依托单位:
CLINICAL RESEARCH TRAINING IN ALCOHOLISM
-
批准号:3530066
-
项目类别:
-
资助金额:$8.85万
-
财政年份:1990
-
负责人:THOMAS P BERESFORD
-
依托单位:
SCREENING EXAMINATIONS FOR COVERT ALCOHOLISM
-
批准号:3110945
-
项目类别:
-
资助金额:$16.56万
-
财政年份:1986
-
负责人:THOMAS P BERESFORD
-
依托单位:
SCREENING EXAMINATIONS FOR COVERT ALCOHOLISM
-
批准号:3110944
-
项目类别:
-
资助金额:$14.76万
-
财政年份:1986
-
负责人:THOMAS P BERESFORD
-
依托单位:
SCREENING EXAMINATIONS FOR COVERT ALCOHOLISM
-
批准号:3110943
-
项目类别:
-
资助金额:$9.58万
-
财政年份:1986
-
负责人:THOMAS P BERESFORD
-
依托单位:
海外基金